March 24, 2023 -- Lausanne, Switzerland-based Lunaphore said Thursday it has closed 40 million Swiss francs (CHF) ($43.5 million) in a Series D1 financing.
The round was led by Ernst-Göhner Stiftung Beteiligungen (EGSB) and included current investors PHC Holdings, Swiss Entrepreneurs Fund, Occident, and Redalpine.
The financing also included a 10-million-euro venture debt facility provided by Norgine Ventures.
Lunaphore, whose goal is to enable spatial biology in the lab, said that it plans to use the funding to strengthen its growing portfolio in spatial biology as well as support commercial execution to address growing demand from customers.
"The funding comes in a meaningful time where we are experiencing excellent traction over the last 12 months since the first launch of our Comet product line," Ata Tuna Ciftlik, CEO of Lunaphore, said in a statement.
The Comet platform enables multiplex staining and image acquisition for the study of human tissue slides, using label-free antibodies that allow for high flexibility.